Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Tirzepatide: The weight-loss drug that also shrinks breast tumors in mice Date: July 13, 2025 Source: The Endocrine Society Summary: In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant weight loss in obese mice but also slashed breast cancer tumor growth
Retatrutide posted 24% body weight loss in Phase 2 by targeting three receptors instead of one
Il margine prefissato saltato
During your consultation, your provider will discuss both options and help determine which medication is best suited to your individual needs and health profile
US$ 21.64
US$ 20.38
US$ 27.40
US$ 26.39
US$ 27.46
US$ 22.03
